Neumann D - Search Results

1

Erythropoietin directly stimulates osteoclast precursors and induces bone loss.

Hiram-Bab S, Liron T, Deshet-Unger N, Mittelman M, Gassmann M, Rauner M, Franke K, Wielockx B, Neumann D, Gabet Y. Hiram-Bab S, et al. Among authors: neumann d. FASEB J. 2015 May;29(5):1890-900. doi: 10.1096/fj.14-259085. Epub 2015 Jan 28. FASEB J. 2015. PMID: 25630969

2

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.

Mittelman M, Neumann D, Peled A, Kanter P, Haran-Ghera N. Mittelman M, et al. Among authors: neumann d. Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5181-6. doi: 10.1073/pnas.081275298. Epub 2001 Apr 17. Proc Natl Acad Sci U S A. 2001. PMID: 11309490 Free PMC article.

3

Erythropoietin and its receptor: signaling and clinical manifestations.

Cohen J, Supino-Rosin L, Barzilay E, Eisen-Lev R, Mittelman M, Neumann D. Cohen J, et al. Among authors: neumann d. Isr Med Assoc J. 2002 Nov;4(11):1072-6. Isr Med Assoc J. 2002. PMID: 12489509 Free article. Review. No abstract available.

4

Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies.

Mittelman M, Zeidman A, Kanter P, Katz O, Oster H, Rund D, Neumann D. Mittelman M, et al. Among authors: neumann d. Eur J Haematol. 2004 Mar;72(3):155-65. doi: 10.1046/j.0902-4441.2003.00190.x. Eur J Haematol. 2004. PMID: 14962233

5

Erythropoietin induced tumour mass reduction in murine lymphoproliferative models.

Katz O, Barzilay E, Skaat A, Herman A, Mittelman M, Neumann D. Katz O, et al. Among authors: neumann d. Acta Haematol. 2005;114(3):177-9. doi: 10.1159/000087896. Acta Haematol. 2005. PMID: 16227685 No abstract available.

6

Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?

Prutchi-Sagiv S, Golishevsky N, Oster HS, Katz O, Cohen A, Naparstek E, Neumann D, Mittelman M. Prutchi-Sagiv S, et al. Among authors: neumann d. Br J Haematol. 2006 Dec;135(5):660-72. doi: 10.1111/j.1365-2141.2006.06366.x. Br J Haematol. 2006. PMID: 17107348 Free article.

7

Erythropoietin in clinical practice: current use, effect on survival, and future directions.

Oster HS, Hoffman M, Prutchi-Sagiv S, Katz O, Neumann D, Mittelman M. Oster HS, et al. Among authors: neumann d. Isr Med Assoc J. 2006 Oct;8(10):703-6. Isr Med Assoc J. 2006. PMID: 17125118 Free article. Review.

8

Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels.

Liron T, Seraya CB, Ish-Shalom M, Souroujon MC, Neumann D. Liron T, et al. Among authors: neumann d. Neuroscience. 2007 Apr 25;146(1):152-9. doi: 10.1016/j.neuroscience.2007.01.024. Epub 2007 Feb 22. Neuroscience. 2007. PMID: 17321053

9

Erythropoietin enhances immune responses in mice.

Katz O, Gil L, Lifshitz L, Prutchi-Sagiv S, Gassmann M, Mittelman M, Neumann D. Katz O, et al. Among authors: neumann d. Eur J Immunol. 2007 Jun;37(6):1584-93. doi: 10.1002/eji.200637025. Eur J Immunol. 2007. PMID: 17458859 Free article.

10

Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?

Prutchi Sagiv S, Lifshitz L, Orkin R, Mittelman M, Neumann D. Prutchi Sagiv S, et al. Among authors: neumann d. Exp Hematol. 2008 Dec;36(12):1682-90. doi: 10.1016/j.exphem.2008.07.010. Epub 2008 Oct 14. Exp Hematol. 2008. PMID: 18922618 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

996 results

Search Page

Filters